Page last updated: 2024-08-22

gadolinium and Cystadenocarcinoma, Serous

gadolinium has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anttila, M; Arponen, O; Hämäläinen, K; Könönen, M; Lindgren, A; Rautiainen, S; Sallinen, H; Vanninen, R	1

Other Studies

1 other study(ies) available for gadolinium and Cystadenocarcinoma, Serous

Article	Year
Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression. PloS one, 2019, Volume: 14, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Cystadenocarcinoma, Serous; Extracellular Space; Female; Gadolinium; Gene Expression; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Perfusion; Prospective Studies; ROC Curve	2019

Article

Year

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.

PloS one, 2019, Volume: 14, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Cystadenocarcinoma, Serous; Extracellular Space; Female; Gadolinium; Gene Expression; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Perfusion; Prospective Studies; ROC Curve

2019